It takes just ten minutes to prepare for a major market rally. By following my three simple steps, you can quickly find a handful of small-cap stocks that will outperform the market over the next 3 months.
But before I reveal my screen criteria, I want to show you why I ...read more
Why You Should Avoid Zynga and the Sham “Social Gaming” Sector
Feb 8th, 2012 | By Greg Guenthner | Category: Featured, Investing Strategies, Penny stocks
Even when you’re scouring the market for fast-growing small-cap stocks, you need to remember the golden rule of investing: don’t lose money.
It’s the rule that every successful investor has used to build wealth. And it’s the same rule that will destroy your trading account if you fail to heed its ...read more
The Only Chinese Growth Story Worth Buying Right Now
Feb 3rd, 2012 | By Greg Guenthner | Category: China, Featured, Growth Stocks
There’s an intriguing growth story in China right now that you need to be following — particularly one specific play that could help you take advantage of a powerful new trend before it catches fire. This growth market is so compelling, in fact, that it’s making me rethink my long-standing ...read more
Finding an Edge When the Market Moves Higher
Feb 2nd, 2012 | By Greg Guenthner | Category: Featured, Small Caps
It is becoming more and more difficult for me to deny the rally we are now witnessing. The market is melting up right before our very eyes. Bears will try to explain away the 5%-plus move in the S&P so far this year as a fluke or a temporary reaction ...read more
Facebook’s IPO Could Cripple the Social Media Market
Jan 31st, 2012 | By Greg Guenthner | Category: Featured, IPOs
The idea of betting big on a hot new IPO in the hopes of making a buck is quickly losing credibility. And it soon might get much, much worse. Facebook — and it’s massive, impending stock offering — could be the nail in the coffin for social media stocks if ...read more
Don’t Get Trapped By Sideways Stocks
Jan 27th, 2012 | By Greg Guenthner | Category: Featured, Investing Strategies, Penny stocks
Economists expected US GDP to expand by a 3% annual rate during the fourth quarter. It didn’t — instead expanding at a 2.8% clip. Traders immediately sold futures, only to buy back stocks an hour later when the market opened.
We should continue to expect this tug-of-war between bulls and bears ...read more
Today’s Market Movers: AAPL, BVSN, and the Great Pizza Rally
Jan 25th, 2012 | By Greg Guenthner | Category: Featured, Investing Strategies, Penny stocks
When you spend your days dissecting countless stocks, you sometimes stumble upon small groups of similar companies having their own private bull market.
Often, the momentum can be traced back to an obvious catalyst — fundamental improvements within the group or a well-publicized buyout in the sector. But sometimes, investors and ...read more
How Investor Confidence Shapes A New Rally
Jan 20th, 2012 | By Greg Guenthner | Category: Featured, Investing Strategies, Penny stocks
Successful trading hinges on the ability to spot meaningful turning points in sentiment and exploiting these important emotional periods during the beginning stages of a new trend. With the major averages flirting with key breakout levels, you need to be able to analyze how market participants will react to higher ...read more
Today’s Market Movers: FSL, OAS, NEI, STEV, NSRS
Jan 18th, 2012 | By Greg Guenthner | Category: Featured, Investing Strategies, Penny stocks
I am seeing a ton of bullish setups this week. It’s more than I’ve seen in a long time — maybe the most since late winter 2011. It’s exciting to see stocks attempting breakouts again, yet worrisome at the same time.
As much as I want to be bullish here, I’m ...read more
3 Potential Pharma Buyout Targets
Jan 12th, 2012 | By Greg Guenthner | Category: Featured, Investing Strategies, Technology
The buyout frenzy that has gripped the pharmaceutical sector during the first two weeks of 2012 will more than likely continue. A long list of expiring patents and plenty of available cash are prompting large-cap pharmaceutical companies to seriously consider takeover opportunities in small-cap biotechs.
But the top-line boost of a ...read more

